DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Rea DW, Gray RG, Bowden SJ.
Overall and subgroup findings of the aTTom trial: A randomised comparison of continuing adjuvant tamoxifen to 10 years compared to stopping after 5 years in 6953 women with ER positive or ER untested early breast cancer.

Eur J Cancer 2013;
49: S402

Download Bibliographical Data

Search in: